Ciprazafone
- Level
- Commodity
- Parent
- 51141500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51141551This classification denotes an anticonvulsant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8RSD11181G. European Medicines Agency schedules Ciprazafone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07466MIG. Ciprazafone generally arises in the molecular formula C19H18CL2N2O2. The term CIPRAZAFONE is an International Non-Proprietary Name or INN. CIPRAZAFONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ciprazafone under HS 29242995 and SITC 51479. As of Q4 2014, CIPRAZAFONE remains the US FDA Preferred Term for this commodity. Ciprazafone bears US NLM identifiers UMLS ID C2699233 and NCI Concept Code C78000. SMILES: CLC1CC(C(N(C(=O)CNC2CC2)C)CC1)C(=O)C1C(CL)CCCC1.
Same parent
Under 51141500 · 80Activities that produce or sell this
KBLI · 8Inherited from family 51140000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.